Free Trial

Theratechnologies (TH) Competitors

C$1.73
-0.02 (-1.14%)
(As of 05/29/2024 ET)

TH vs. PLI, ABCN, FRX, EMC, MDNA, BCT, IPA, ONC, SCYB, and COM

Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Fennec Pharmaceuticals (FRX), Emblem (EMC), Medicenna Therapeutics (MDNA), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), and 138267 (COM.TO) (COM). These companies are all part of the "biotechnology" industry.

Theratechnologies vs.

ProMetic Life Sciences (TSE:PLI) and Theratechnologies (TSE:TH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings, institutional ownership and community ranking.

Theratechnologies has higher revenue and earnings than ProMetic Life Sciences. Theratechnologies is trading at a lower price-to-earnings ratio than ProMetic Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ProMetic Life SciencesC$39.91M0.00-C$1.47B-C$63.06N/A
TheratechnologiesC$78.10M1.02-C$18M-C$0.79-2.19

ProMetic Life Sciences received 173 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 67.69% of users gave ProMetic Life Sciences an outperform vote while only 63.44% of users gave Theratechnologies an outperform vote.

CompanyUnderperformOutperform
ProMetic Life SciencesOutperform Votes
442
67.69%
Underperform Votes
211
32.31%
TheratechnologiesOutperform Votes
269
63.44%
Underperform Votes
155
36.56%

Theratechnologies has a consensus price target of C$5.50, indicating a potential upside of 217.92%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ProMetic Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Theratechnologies
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Theratechnologies had 3 more articles in the media than ProMetic Life Sciences. MarketBeat recorded 3 mentions for Theratechnologies and 0 mentions for ProMetic Life Sciences. ProMetic Life Sciences' average media sentiment score of 0.42 beat Theratechnologies' score of 0.00 indicating that Theratechnologies is being referred to more favorably in the news media.

Company Overall Sentiment
ProMetic Life Sciences Neutral
Theratechnologies Neutral

ProMetic Life Sciences has a net margin of 0.00% compared to ProMetic Life Sciences' net margin of -23.04%. Theratechnologies' return on equity of 0.00% beat ProMetic Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ProMetic Life SciencesN/A N/A N/A
Theratechnologies -23.04%-1,116.86%-4.55%

48.9% of Theratechnologies shares are owned by institutional investors. 6.3% of Theratechnologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Theratechnologies beats ProMetic Life Sciences on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TH vs. The Competition

MetricTheratechnologiesBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$79.55MC$254.87MC$5.11BC$5.36B
Dividend Yield3.76%3.36%2.82%5.58%
P/E Ratio-2.19243.44183.0623.78
Price / Sales1.0217,048.312,433.762,807.80
Price / Cash3.7611.6534.9379.63
Price / Book-3.206.805.503.51
Net Income-C$18M-C$15.38MC$105.53MC$287.14M
7 Day Performance1.17%1.19%0.64%-0.08%
1 Month Performance-2.26%5.42%2.54%2.17%
1 Year Performance39.52%0.02%5.34%30.85%

Theratechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PLI
ProMetic Life Sciences
0 of 5 stars
N/AN/AN/AC$317.06MC$39.91M-0.22487
ABCN
VIVO Cannabis
0 of 5 stars
C$1.32
+5.6%
N/A+0.0%C$256.62MN/A0.00N/AGap Up
FRX
Fennec Pharmaceuticals
0 of 5 stars
C$9.16
-6.1%
N/A-1.7%C$248.24MC$44.95M183.2029Gap Down
EMC
Emblem
0 of 5 stars
$1.88
+1.6%
N/A+0.0%$245.45M$5.71M-9.89N/A
MDNA
Medicenna Therapeutics
0 of 5 stars
C$2.36
+0.9%
N/A+176.8%C$176.48MN/A-10.2616Positive News
BCT
BriaCell Therapeutics
0 of 5 stars
C$10.60
-3.8%
N/A+0.0%C$168.68MN/A-28.195
IPA
ImmunoPrecise Antibodies
0 of 5 stars
C$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3073Gap Down
ONC
Oncolytics Biotech
0.5483 of 5 stars
C$1.49
+2.8%
C$3.00
+101.3%
-41.3%C$112.38MN/A-3.7329
SCYB
Scythian Biosciences
0 of 5 stars
C$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
0 of 5 stars
N/AN/AN/AC$102.19MN/A0.00N/ANews Coverage

Related Companies and Tools

This page (TSE:TH) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners